[
  {
    "name": "compoundName",
      "description": "",
      "columnType": "STRING",
      "maximumSize": 250,
      "enumValues": [
      {
        "value": "A-1210477",
        "description": "An MCL-1 inhibitor.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/2015744"
      },
      {
        "value": "ABBVIE1",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE2",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE3",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE4",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE5",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE6",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE7",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE8",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABT-199",
        "description": "An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C103147"
      },
      {
        "value": "DOXORUBICIN",
        "description": "An anthracycline antibiotic with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C456"
      },
      {
        "value": "BI2536",
        "description": "https://www.ncbi.nlm.nih.gov/mesh/67518477",
        "source": "Polo-like kinase 1 inhibitor."
      },
      {
        "value": "BORTEZOMIB",
        "description": "A dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C1851"
      },
      {
        "value": "CARFILZOMIB",
        "description": "An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C52196"
      },
      {
        "value": "MEDIA",
        "description": "A liquid or gel containing nutrients, salts, and other factors formulated to support the growth of microorganisms, cells, or plants.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C85504"
      },
      {
        "value": "CPD22",
        "description": "A novel ILK inhibitor, which exhibit[s] high in vitro potency against a panel of prostate and breast cancer cell lines.",
        "source": "https://www.ncbi.nlm.nih.gov/pubmed/21823616"
      },
      {
        "value": "CRIZOTINIB",
        "description": "An orally available aminopyridine-based inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C74061"
      },
      {
        "value": "CURCUMIN",
        "description": "A phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmacologic properties.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C401"
      },
      {
        "value": "DARATUMUMAB",
        "description": "A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C74007"
      },
      {
        "value": "DEFACTINIB",
        "description": "An orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C79809"
      },
      {
        "value": "DEXAMETHASONE",
        "description": "A synthetic adrenal corticosteroid with potent anti-inflammatory properties.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C422"
      },
      {
        "value": "DINACICLIB",
        "description": "A pyrazolo[1,5-a]pyrimidine with potential antineoplastic activity. Dinaciclib selectively inhibits cyclin dependent kinases CDK1, CDK2, CDK5, and CDK9.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C78854"
      },
      {
        "value": "DMSO",
        "description": "A highly polar organic liquid that is used widely as a chemical solvent and a free radical scavenger.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C437"
      },
      {
        "value": "GGTI-2418",
        "description": "A substance that inhibits protein geranylgeranyltransferase type 1 (GGTase-I), with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C104414"
      },
      {
        "value": "INCB054329",
        "description": "An inhibitor of the Bromodomain and Extra-Terminal (BET) family of bromodomain-containing proteins with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C121948"
      },
      {
        "value": "INK128",
        "description": "An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C90548"
      },
      {
        "value": "IRAK1-4(INHIBITOR)407601",
        "description": "Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor.",
        "source": "https://pubchem.ncbi.nlm.nih.gov/compound/IRAK-1_4_Inhibitor"
      },
      {
        "value": "iGG",
        "description": "An immunoglobulin isotype (subclass) that characterizes secondary immune responses.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C568"
      },
      {
        "value": "IXAZOMIB",
        "description": "An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C97940"
      },
      {
        "value": "KPT-330",
        "description": "An orally available, small molecule inhibitor of CRM1 (chromosome region maintenance 1 protein, exportin 1 or XPO1), with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C102546"
      },
      {
        "value": "LENALIDOMIDE",
        "description": "A thalidomide analog with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C2668"
      },
      {
        "value": "MA7-038",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "MELPHALAN",
        "description": "A phenylalanine derivative of nitrogen mustard with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C633"
      },
      {
        "value": "MK2206",
        "description": "An orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C90581"
      },
      {
        "value": "MTI101",
        "description": "MTI-101 (cyclized HYD1) binds a CD44 containing complex.",
        "source": "https://www.ncbi.nlm.nih.gov/pubmed/24048737"
      },
      {
        "value": "PANOBINOSTAT",
        "description": "A cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC).",
        "source": "http://purl.obolibrary.org/obo/NCIT_C66948"
      },
      {
        "value": "POMALIDOMIDE",
        "description": "An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C72560"
      },
      {
        "value": "PONATINIB",
        "description": "An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C95777"
      },
      {
        "value": "RICOLINOSTAT",
        "description": "An orally bioavailable, specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C96431"
      },
      {
        "value": "SILMITASERTIB",
        "description": "Silmitasertib selectively binds to and inhibits the enzyme casein kinase II (CK2)",
        "source": "http://purl.obolibrary.org/obo/NCIT_C85460"
      },
      {
        "value": "SNS-032",
        "description": "A small aminothiazole molecule and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C62523"
      },
      {
        "value": "SR3029",
        "description": "Highly selective casein kinase 1delta/1epsilon inhibitor with potent antiproliferative properties.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/67585785"
      },
      {
        "value": "THZ1",
        "description": "A low nanomolar inhibitor of cell proliferation and biochemical CDK7 activity.",
        "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244910/"
      },
      {
        "value": "UMI-77",
        "description": "An Mcl-1 inhibitor.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/2003359"
      },
      {
        "value": "VOLASERTIB",
        "description": "A dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C79844"
      }
    ] 
  },
  {
    "name": "secondCompoundName",
    "description": "",
    "columnType": "STRING",
    "maximumSize": 250,
      "enumValues": [
      {
        "value": "A-1210477",
        "description": "An MCL-1 inhibitor.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/2015744"
      },
      {
        "value": "ABBVIE1",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE2",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE3",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE4",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE5",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE6",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE7",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABBVIE8",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "ABT-199",
        "description": "An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C103147"
      },
      {
        "value": "DOXORUBICIN",
        "description": "An anthracycline antibiotic with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C456"
      },
      {
        "value": "BI2536",
        "description": "https://www.ncbi.nlm.nih.gov/mesh/67518477",
        "source": "Polo-like kinase 1 inhibitor."
      },
      {
        "value": "BORTEZOMIB",
        "description": "A dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C1851"
      },
      {
        "value": "CARFILZOMIB",
        "description": "An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C52196"
      },
      {
        "value": "MEDIA",
        "description": "A liquid or gel containing nutrients, salts, and other factors formulated to support the growth of microorganisms, cells, or plants.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C85504"
      },
      {
        "value": "CPD22",
        "description": "A novel ILK inhibitor, which exhibit[s] high in vitro potency against a panel of prostate and breast cancer cell lines.",
        "source": "https://www.ncbi.nlm.nih.gov/pubmed/21823616"
      },
      {
        "value": "CRIZOTINIB",
        "description": "An orally available aminopyridine-based inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C74061"
      },
      {
        "value": "CURCUMIN",
        "description": "A phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmacologic properties.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C401"
      },
      {
        "value": "DARATUMUMAB",
        "description": "A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C74007"
      },
      {
        "value": "DEFACTINIB",
        "description": "An orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C79809"
      },
      {
        "value": "DEXAMETHASONE",
        "description": "A synthetic adrenal corticosteroid with potent anti-inflammatory properties.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C422"
      },
      {
        "value": "DINACICLIB",
        "description": "A pyrazolo[1,5-a]pyrimidine with potential antineoplastic activity. Dinaciclib selectively inhibits cyclin dependent kinases CDK1, CDK2, CDK5, and CDK9.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C78854"
      },
      {
        "value": "DMSO",
        "description": "A highly polar organic liquid that is used widely as a chemical solvent and a free radical scavenger.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C437"
      },
      {
        "value": "GGTI-2418",
        "description": "A substance that inhibits protein geranylgeranyltransferase type 1 (GGTase-I), with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C104414"
      },
      {
        "value": "INCB054329",
        "description": "An inhibitor of the Bromodomain and Extra-Terminal (BET) family of bromodomain-containing proteins with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C121948"
      },
      {
        "value": "INK128",
        "description": "An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C90548"
      },
      {
        "value": "IRAK1-4(INHIBITOR)407601",
        "description": "Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor.",
        "source": "https://pubchem.ncbi.nlm.nih.gov/compound/IRAK-1_4_Inhibitor"
      },
      {
        "value": "iGG",
        "description": "An immunoglobulin isotype (subclass) that characterizes secondary immune responses.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C568"
      },
      {
        "value": "IXAZOMIB",
        "description": "An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C97940"
      },
      {
        "value": "KPT-330",
        "description": "An orally available, small molecule inhibitor of CRM1 (chromosome region maintenance 1 protein, exportin 1 or XPO1), with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C102546"
      },
      {
        "value": "LENALIDOMIDE",
        "description": "A thalidomide analog with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C2668"
      },
      {
        "value": "MA7-038",
        "description": "Internal research compound.",
        "source": "Moffitt"
      },
      {
        "value": "MELPHALAN",
        "description": "A phenylalanine derivative of nitrogen mustard with antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C633"
      },
      {
        "value": "MK2206",
        "description": "An orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C90581"
      },
      {
        "value": "MTI101",
        "description": "MTI-101 (cyclized HYD1) binds a CD44 containing complex.",
        "source": "https://www.ncbi.nlm.nih.gov/pubmed/24048737"
      },
      {
        "value": "PANOBINOSTAT",
        "description": "A cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC).",
        "source": "http://purl.obolibrary.org/obo/NCIT_C66948"
      },
      {
        "value": "POMALIDOMIDE",
        "description": "An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C72560"
      },
      {
        "value": "PONATINIB",
        "description": "An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C95777"
      },
      {
        "value": "RICOLINOSTAT",
        "description": "An orally bioavailable, specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C96431"
      },
      {
        "value": "SILMITASERTIB",
        "description": "Silmitasertib selectively binds to and inhibits the enzyme casein kinase II (CK2)",
        "source": "http://purl.obolibrary.org/obo/NCIT_C85460"
      },
      {
        "value": "SNS-032",
        "description": "A small aminothiazole molecule and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C62523"
      },
      {
        "value": "SR3029",
        "description": "Highly selective casein kinase 1delta/1epsilon inhibitor with potent antiproliferative properties.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/67585785"
      },
      {
        "value": "THZ1",
        "description": "A low nanomolar inhibitor of cell proliferation and biochemical CDK7 activity.",
        "source": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244910/"
      },
      {
        "value": "UMI-77",
        "description": "An Mcl-1 inhibitor.",
        "source": "https://www.ncbi.nlm.nih.gov/mesh/2003359"
      },
      {
        "value": "VOLASERTIB",
        "description": "A dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity.",
        "source": "http://purl.obolibrary.org/obo/NCIT_C79844"
      }
    ] 
  },
     {
    "name": "drugScreenType",
    "description": "String describing general class of drug screen",
    "columnType": "STRING",
    "maximumSize": 250,
    "enumValues":[
      {
        "value": "singleMolecule",
        "description": "An experiment in which a single molecule was used in an assay",
        "source": ""
      },
      {
        "value": "smallMoleculeLibraryScreen",
        "description": "High throughput sample analysis of small molecules for purpose such as drug discovery, or biochemical, genetic or pharmacological tests.",
        "source": " http://purl.obolibrary.org/obo/ERO_0001726"
      },
      {
        "value":"combinationLibraryScreen",
        "description":"High throughput sample analysis of collections of compounds that provide a variety of chemically diverse structures that can be used to identify structure types that have affinity with pharmacological targets.",
        "source":"http://purl.obolibrary.org/obo/ERO_0001686"
      },
      {
        "value": "combinationScreen",
        "description":"",
        "source":""
        }
    ]
  },
  {
      "name": "compoundDose",
      "description": "",
      "columnType": "DOUBLE",
      "enumValues": []
  },
    {
        "name":"compoundDoseUnit",
        "description":"",
        "columnType":"STRING",
      "maximumSize": 250,
      "enumValues": []
    },
    {
        "name":"secondCompoundDose",
        "description":"",
        "columnType":"DOUBLE",
        "enumValues":[]
    },
    {
        "name":"secondCompoundDoseUnit",
        "description":"",
        "columnType":"STRING",
        "maximumSize": 250,
        "enumValues": []
    }
  ]
